table of content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Neurological Biomarkers Revenue
1.4 Market Analysis by Type
1.4.1 Global Neurological Biomarkers Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Proteomics
1.4.3 Genomics
1.4.4 Imaging
1.4.5 Bioinformatics
1.5 Market by Application
1.5.1 Global Neurological Biomarkers Market Share by Application: 2022-2027
1.5.2 Diagnostics
1.5.3 Drug Discovery
1.5.4 Personalized Medicine
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Neurological Biomarkers Market
1.8.1 Global Neurological Biomarkers Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Neurological Biomarkers Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Neurological Biomarkers Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Neurological Biomarkers Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Neurological Biomarkers Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Neurological Biomarkers Sales Volume Market Share by Region (2016-2021)
3.2 Global Neurological Biomarkers Sales Revenue Market Share by Region (2016-2021)
3.3 North America Neurological Biomarkers Sales Volume
3.3.1 North America Neurological Biomarkers Sales Volume Growth Rate (2016-2021)
3.3.2 North America Neurological Biomarkers Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Neurological Biomarkers Sales Volume
3.4.1 East Asia Neurological Biomarkers Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Neurological Biomarkers Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Neurological Biomarkers Sales Volume (2016-2021)
3.5.1 Europe Neurological Biomarkers Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Neurological Biomarkers Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Neurological Biomarkers Sales Volume (2016-2021)
3.6.1 South Asia Neurological Biomarkers Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Neurological Biomarkers Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Neurological Biomarkers Sales Volume (2016-2021)
3.7.1 Southeast Asia Neurological Biomarkers Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Neurological Biomarkers Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Neurological Biomarkers Sales Volume (2016-2021)
3.8.1 Middle East Neurological Biomarkers Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Neurological Biomarkers Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Neurological Biomarkers Sales Volume (2016-2021)
3.9.1 Africa Neurological Biomarkers Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Neurological Biomarkers Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Neurological Biomarkers Sales Volume (2016-2021)
3.10.1 Oceania Neurological Biomarkers Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Neurological Biomarkers Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Neurological Biomarkers Sales Volume (2016-2021)
3.11.1 South America Neurological Biomarkers Sales Volume Growth Rate (2016-2021)
3.11.2 South America Neurological Biomarkers Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Neurological Biomarkers Sales Volume (2016-2021)
3.12.1 Rest of the World Neurological Biomarkers Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Neurological Biomarkers Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Neurological Biomarkers Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Neurological Biomarkers Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Neurological Biomarkers Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Neurological Biomarkers Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Neurological Biomarkers Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Neurological Biomarkers Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Neurological Biomarkers Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Neurological Biomarkers Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Neurological Biomarkers Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Neurological Biomarkers Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Neurological Biomarkers Sales Volume Market Share by Type (2016-2021)
14.2 Global Neurological Biomarkers Sales Revenue Market Share by Type (2016-2021)
14.3 Global Neurological Biomarkers Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Neurological Biomarkers Consumption Volume by Application (2016-2021)
15.2 Global Neurological Biomarkers Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Neurological Biomarkers Business
16.1 Thermo Fisher Scientific
16.1.1 Thermo Fisher Scientific Company Profile
16.1.2 Thermo Fisher Scientific Neurological Biomarkers Product Specification
16.1.3 Thermo Fisher Scientific Neurological Biomarkers Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Merck
16.2.1 Merck Company Profile
16.2.2 Merck Neurological Biomarkers Product Specification
16.2.3 Merck Neurological Biomarkers Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Quest Diagnostics
16.3.1 Quest Diagnostics Company Profile
16.3.2 Quest Diagnostics Neurological Biomarkers Product Specification
16.3.3 Quest Diagnostics Neurological Biomarkers Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Abbott
16.4.1 Abbott Company Profile
16.4.2 Abbott Neurological Biomarkers Product Specification
16.4.3 Abbott Neurological Biomarkers Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Roche
16.5.1 Roche Company Profile
16.5.2 Roche Neurological Biomarkers Product Specification
16.5.3 Roche Neurological Biomarkers Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Illumina
16.6.1 Illumina Company Profile
16.6.2 Illumina Neurological Biomarkers Product Specification
16.6.3 Illumina Neurological Biomarkers Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 Bio-Rad Laboratories
16.7.1 Bio-Rad Laboratories Company Profile
16.7.2 Bio-Rad Laboratories Neurological Biomarkers Product Specification
16.7.3 Bio-Rad Laboratories Neurological Biomarkers Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 QIAGEN
16.8.1 QIAGEN Company Profile
16.8.2 QIAGEN Neurological Biomarkers Product Specification
16.8.3 QIAGEN Neurological Biomarkers Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 Myriad RBM
16.9.1 Myriad RBM Company Profile
16.9.2 Myriad RBM Neurological Biomarkers Product Specification
16.9.3 Myriad RBM Neurological Biomarkers Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.10 Cisbio Bioassays
16.10.1 Cisbio Bioassays Company Profile
16.10.2 Cisbio Bioassays Neurological Biomarkers Product Specification
16.10.3 Cisbio Bioassays Neurological Biomarkers Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.11 Athena Diagnostics
16.11.1 Athena Diagnostics Company Profile
16.11.2 Athena Diagnostics Neurological Biomarkers Product Specification
16.11.3 Athena Diagnostics Neurological Biomarkers Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.12 BGI
16.12.1 BGI Company Profile
16.12.2 BGI Neurological Biomarkers Product Specification
16.12.3 BGI Neurological Biomarkers Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.13 Wuxi APP
16.13.1 Wuxi APP Company Profile
16.13.2 Wuxi APP Neurological Biomarkers Product Specification
16.13.3 Wuxi APP Neurological Biomarkers Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.14 Aepodia
16.14.1 Aepodia Company Profile
16.14.2 Aepodia Neurological Biomarkers Product Specification
16.14.3 Aepodia Neurological Biomarkers Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.15 Proteome Sciences
16.15.1 Proteome Sciences Company Profile
16.15.2 Proteome Sciences Neurological Biomarkers Product Specification
16.15.3 Proteome Sciences Neurological Biomarkers Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.16 Genewiz
16.16.1 Genewiz Company Profile
16.16.2 Genewiz Neurological Biomarkers Product Specification
16.16.3 Genewiz Neurological Biomarkers Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Neurological Biomarkers Manufacturing Cost Analysis
17.1 Neurological Biomarkers Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Neurological Biomarkers
17.4 Neurological Biomarkers Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Neurological Biomarkers Distributors List
18.3 Neurological Biomarkers Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Neurological Biomarkers (2022-2027)
20.2 Global Forecasted Revenue of Neurological Biomarkers (2022-2027)
20.3 Global Forecasted Price of Neurological Biomarkers (2016-2027)
20.4 Global Forecasted Production of Neurological Biomarkers by Region (2022-2027)
20.4.1 North America Neurological Biomarkers Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Neurological Biomarkers Production, Revenue Forecast (2022-2027)
20.4.3 Europe Neurological Biomarkers Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Neurological Biomarkers Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Neurological Biomarkers Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Neurological Biomarkers Production, Revenue Forecast (2022-2027)
20.4.7 Africa Neurological Biomarkers Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Neurological Biomarkers Production, Revenue Forecast (2022-2027)
20.4.9 South America Neurological Biomarkers Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Neurological Biomarkers Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Neurological Biomarkers by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Neurological Biomarkers by Country
21.2 East Asia Market Forecasted Consumption of Neurological Biomarkers by Country
21.3 Europe Market Forecasted Consumption of Neurological Biomarkers by Countriy
21.4 South Asia Forecasted Consumption of Neurological Biomarkers by Country
21.5 Southeast Asia Forecasted Consumption of Neurological Biomarkers by Country
21.6 Middle East Forecasted Consumption of Neurological Biomarkers by Country
21.7 Africa Forecasted Consumption of Neurological Biomarkers by Country
21.8 Oceania Forecasted Consumption of Neurological Biomarkers by Country
21.9 South America Forecasted Consumption of Neurological Biomarkers by Country
21.10 Rest of the world Forecasted Consumption of Neurological Biomarkers by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
